Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu CEDMedtech is an active Chinese medical device company specializing in innovative interventional and neuromodulation technologies. Its portfolio includes a novel flow diverter stent ("Choydar FD") for intracranial aneurysm treatment, a percutaneous peripheral nerve stimulation system for postherpetic neuralgia, and embolization microsphere products targeting musculoskeletal pain such as tennis elbow. Early clinical studies suggest promising safety and efficacy profiles, but most programs are still in exploratory or early-stage clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu CEDMedtech.